A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19
Clinical trial NCT05102643 · UNKNOWN
Trial details
- NCT number
- NCT05102643
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-18
- Primary completion
- 2022-06-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.